[Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro].
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000328:Adult; D001095:Arachidonic Acids / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology*; D003094:Collagen / Q000494:pharmacology; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D011451:Prostaglandin-Endoperoxide Synthases / Q000097:blood*; D013929:Thromboxane B2 / Q000037:antagonists & inhibitors / Q000096:biosynthesis*
D001095:Arachidonic Acids; D013929:Thromboxane B2; D000244:Adenosine Diphosphate; D003094:Collagen; D011451:Prostaglandin-Endoperoxide Synthases; D001241:Aspirin; D004837:Epinephrine
Aktywność cyklooksygenazy oraz agregacja i synteza TxB2 pod wpływem róznych stymulatorów po zastosowaniu in vivo oraz in vitro inhibitora czynności płytek (preparatu Aspro Clear).